Navigation Links
Brain Science Institute announces license agreement to develop treatments for neurological disease
Date:3/12/2010

Johns Hopkins University's newly formed Brain Science Institute's NeuroTranslational Program has entered into a licensing agreement with pharmaceutical company Eisai Inc. to discover and develop small molecule glutamate carboxypeptidase II (GCPII) inhibitors.

The NeuroTranslational Program was launched in 2009 staffed with seasoned drug-discovery scientists to work side by side with Johns Hopkins faculty to help translate basic science discoveries into small molecule therapeutics.

Under the terms of the agreement, Eisai has granted the Brain Science Institute, or BSI, non-exclusive U.S. rights to use its GCPII technology to generate inhibitor molecules for diseases of the central and peripheral nervous system, including peripheral neuropathy and neurodegeneration, Alzheimer's disease, stroke, and ALS, as well as non-central nervous system diseases.

BSI will be responsible for the GCPII research, drug discovery and preclinical activities. Eisai will have an exclusive option to develop and commercialize any drug molecules generated from the collaboration, which will be led by a joint steering committee of representatives from both entities. Barbara Slusher, Ph.D., chief scientific officer of the BSI's NeuroTranslational Program, will serve as the academic lead of the steering committee, along with the NeuroTranslational Program's Director of Medicinal Chemistry Takashi Tsukamoto, Ph.D.

"We believe this collaboration will strengthen our ability to bring a novel class of compounds to patients," said Slusher.

"It is a great accomplishment for this team to announce a licensing agreement of this kind within its first year of operation," said Jeffery Rothstein, M.D., professor of neurology and co-director of the program.


'/>"/>

Contact: Gary Stephenson
gstephenson@jhmi.edu
410-955-5384
Johns Hopkins Medical Institutions
Source:Eurekalert

0

GOOD

Page: 1

Related medicine news :

1. American Brain Tumor Association Recognizes Philadelphia Family Foundation With Annual Award
2. OASIS Recognized for Brain Fitness Programming
3. Carnegie Mellon research provides insight into brains decision-making process
4. Researchers discover brain tumors grow-or-go switch
5. U discovery gives insight into brain replay process
6. UW Symposium: How Disease, Therapy, Drugs and Meditation Reshape the Brain
7. iPhone Memory Aid for Scatterbrains, Aging Baby Boomers and Busy, Forgetful People
8. After a fight with a partner, brain activity predicts emotional resiliency
9. Free Brain IQ Quiz, Activities for Home “Brain-Boosting” and Seminar Offered from LearningRX Denver during National Brain Awareness Month
10. Ritalin Boosts Learning by Increasing Brain Plasticity, According to UCSF Research
11. Golf Fore Brain Cancer Research at the Barry Spiegelman Memorial Golf Classic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (PRWEB) May 23, 2013 Click here ... Canadian tech start-ups are increasingly seeing their success develop ... larger US-based companies, according to new research carried ... , The company has compiled its research into ... The findings of the research have shown the general ...
(Date:5/23/2013)... Jeanne Ettelson, president of Beyond OCD ... only free OCD support group in Chicago. Launched ... sufferers, the group is lead by psychologists who specialize ... allows group participants to learn accurate information about OCD, ... “Participants in Beyond OCD’s support group benefit from ...
(Date:5/23/2013)... Cheap Concert Tickets announces that Paul McCartney will ... North America. This well known ticket website has slashed ... help McCartney fans see Sir Paul live in concert. ... is also offering the customer appreciation code SAVE for additional ... she is also a huge McCartney fan and plans to ...
(Date:5/23/2013)... Schools should ensure that kids get at least ... support their health and boost performance in school, ... previous studies show 60 minutes of vigorous to ... estimated that only about 50 percent of school-aged ... the report from the Institute of Medicine. ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- Symptoms of ... psychiatric disorders, complicating diagnosis and treatment. But researchers ... that may be unique to borderline personality disorder: ... face. , , "They have difficulty processing facial ... a neutral face," said Anthony Ruocco, a clinical ...
Breaking Medicine News(10 mins):Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 2Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 4Health News:Beyond OCD Support Group Marks Fifth Anniversary 2Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2Health News:U.S. School Kids Should Get Hour of Exercise Daily: Report 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 3
... states that post-menopausal women who cut their fat intake and ... grains tend to lose weight. // , ,The study ... gain and increasing of obesity rates. ,The results ... a low-fat diet without any weight-loss goals. In the first ...
... scientists reports that 'mad cow'-like diseases have not been a ... that are known to be associated with disease transmission.// ... Genome Research, Prof. Jaume Bertranpetit at the Universitat Pompeu Fabra ... to show that balancing selection associated with cannibalism has not ...
... Qiang at the National Health Conference has urged the health ... poor and needy instead of spending lot of funds on ... authorities not to be partial in offering health care to ... freezing funds for hospital expansion, infrastructure development as it is ...
... A recent study reported in the American Journal of ... of attempting suicide but rather decrease the suicide risk. ... antidepressant drugs should be closely monitored to find their ... cause adverse conditions. ,The researchers ...
... now that Vitamin D supplementation helps women but in a ... women could lead to long-lasting reduction in osteoporotic fractures in ... shown that children whose mothers were lacking in vitamin D ... ,It is a common sight and medical fact that Vitamin ...
... was always profiled as a disease of the Neurons ... finger on the participation// of Astrocytes in regulating blood ... and Alzheimer’s. ,According to Neuroscientist, Dr. Maiken ... path-breaking research signals the potential contribution of Astrocytes (Star ...
Cached Medicine News:Health News:New Study Questions Cannibalism As A Worldwide Selective Force 2
(Date:5/23/2013)... 2013  MedVantx, Inc., the company that has pioneered ... today the Company has completed a major expansion of ... products and the upgrade of its systems to offer ... its specialty home delivery pharmacy in Sioux ... manufacturers, physicians, health systems and payors novel distribution services, ...
(Date:5/23/2013)...  Echo Pharma Acquisition Limited ("Royalty Pharma") announced today ... Threshold from 90 percent to 50 percent of Maximum ... with the terms of the Revised Offer Document issued ... Under the terms of the Increased Offer, Royalty Pharma ... ) for $12.50 per share in cash. The Increased ...
(Date:5/23/2013)... May 23, 2013  PAREXEL International Corporation (NASDAQ: ... presenting at the Jefferies Healthcare Conference in New York.  ... and Chief Financial Officer, will be making a presentation ... on Monday, June 3, 2013. A live ... "Investors" section of PAREXEL,s website at www.PAREXEL.com ...
Breaking Medicine Technology:MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10PAREXEL International To Present At Jefferies Healthcare Conference 2
... 2011 Caliper Life Sciences, Inc. (NASDAQ: ... for life science companies, today announced that Kevin Hrusovsky, President ... BioConference Live event, which was held on October 26, and ... Forum on October 27 held at Harvard Medical School. ...
... Conn., Nov. 7, 2011 Boehringer Ingelheim Pharmaceuticals, Inc. ... a Phase 2b study, SOUND-C2, that showed the combination ... compounds – the protease inhibitor BI 201335 and the ... successful in reducing viral load below the lower limit ...
Cached Medicine Technology:Caliper CEO Kevin Hrusovsky Presented Vision for Revolutionizing Medicine 2Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 2Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 3Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 4Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 5
PG Magnum Ring Curettes, total length 12.6" (32 cm), handle length 7.8" (20 cm), handle diameter 1.12" (3 cm), working distance 4.7" (12 cm), dual-coned, precision sharpened rings....
Karlin XL Magnum Cup Curettes, extra long (XL) curettes, black handles, lightweight, length 13 1/4" (33.7 cm), handle length 8 1/2" (21 cm), handle diameter 1 1/4" (32 cm)....
XL Cervical Curette comes with a bayonet design and satin black handles having instrument length 9.5" (24 cm), working distance4.1" (10.4 cm) and handle width 0.6" (1.5 cm)....
Caspar Curette, 250 mm, 10"....
Medicine Products: